Literature DB >> 24749654

Leuconostoc as a Cause of Endophthalmitis Post-intravitreal Injection of Ranibizumab.

Nadyr P Damasceno1, Soraya A Horowitz1, Eduardo F Damasceno2.   

Abstract

PURPOSE: The authors report a case of endophthalmitis after intravitreal injection of ranibizumab.
METHODS: After searching for extensive laboratory tests to isolate the etiologic agent
Results: The agent was determined as Leuconostoc mesenteroides, gram-positive cocci, vancomycin resistant. DISCUSSION: Considerations regarding this bacterium were done by calling attention to its rarity, difficulty of isolation, and action on secondary comorbidities as opportunistic pathogen.

Entities:  

Keywords:  Complications; Leuconostocaceae; endophthalmitis; intravitreal injections; opportunistic pathogens; ranibizumab

Mesh:

Substances:

Year:  2014        PMID: 24749654     DOI: 10.3109/09273948.2014.898073

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  4 in total

Review 1.  Endophthalmitis caused by Gram-positive organisms with reduced vancomycin susceptibility: literature review and options for treatment.

Authors:  Nidhi Relhan; Thomas A Albini; Avinash Pathengay; Ajay E Kuriyan; Darlene Miller; Harry W Flynn
Journal:  Br J Ophthalmol       Date:  2015-12-23       Impact factor: 4.638

2.  Endophthalmitis following intravitreal injection of anti-VEGF agents: long-term outcomes and the identification of unusual micro-organisms.

Authors:  Mira M Sachdeva; Ala Moshiri; Henry A Leder; Adrienne W Scott
Journal:  J Ophthalmic Inflamm Infect       Date:  2016-01-12

3.  Acute Endophthalmitis Caused by Leuconostoc spp. following Intravitreal Bevacizumab Injection.

Authors:  Supreet Singh; Chirag V Patel; Kamal Kishore
Journal:  Case Rep Ophthalmol       Date:  2017-10-30

4.  Treatment of Radiation Retinopathy with Intravitreal Injection of Ranibizumab (Lucentis®).

Authors:  Soraya Alessandra Horowitz; Nadyr P Damasceno; Eduardo F Damasceno
Journal:  Int Med Case Rep J       Date:  2020-02-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.